Jane Street’s PMV Pharmaceuticals PMVP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$23.8K Sell
14,245
-25,962
-65% -$33.6K ﹤0.01% 11234
2026
Q2
$53.9K Sell
40,207
-83,807
-68% -$108K ﹤0.01% 10900
2026
Q1
$154K Sell
124,014
-374,627
-75% -$476K ﹤0.01% 10368
2025
Q4
$623K Buy
498,641
+116,591
+31% +$156K ﹤0.01% 7198
2025
Q3
$535K Buy
+382,050
New +$529K ﹤0.01% 7718
2025
Q1
– Sell
-49,870
Closed -$75.3K – 10353
2024
Q4
$75.3K Sell
49,870
-24,219
-33% -$38.4K ﹤0.01% 8863
2024
Q3
$110K Sell
74,089
-89,957
-55% -$139K ﹤0.01% 8956
2024
Q2
$266K Buy
164,046
+136,066
+486% +$245K ﹤0.01% 7978
2024
Q1
$47.6K Buy
27,980
+803
+3% +$1.5K ﹤0.01% 8750
2023
Q4
$84.2K Sell
27,177
-11,857
-30% -$31.4K ﹤0.01% 8648
2023
Q3
$240K Buy
+39,034
New +$268K ﹤0.01% 7381
2023
Q2
– Sell
-235,447
Closed -$1.12M – 9380
2023
Q1
$1.12M Buy
235,447
+162,927
+225% +$1.15M ﹤0.01% 4789
2022
Q4
$631K Buy
72,520
+48,593
+203% +$518K ﹤0.01% 5736
2022
Q3
$285K Sell
23,927
-1,048
-4% -$15.1K ﹤0.01% 7673
2022
Q2
$356K Buy
+24,975
New +$363K ﹤0.01% 7324
2020
Q4
– Sell
-31,349
Closed -$1.11M – 7964
2020
Q3
$1.11M Buy
+31,349
New +$1.15M ﹤0.01% 3930

Other funds holding PMVP

Jane Street's PMVP Position: Q3 2026 in Review

Jane Street reduced its PMV Pharmaceuticals (PMVP) stake by 65% in Q3 2026, selling an estimated $33.6K and leaving 14,245 shares worth $23.8K. The position accounts for ﹤0.01% of the portfolio, ranked #11234.

Jane Street first reported a position in PMVP in Q3 2020 and has held it in 16 quarters since. The position peaked at $1.12M in Q1 2023. 36 funds tracked by Wall St. Rank hold PMVP as of Q3 2026.

  • Jane Street held 14,245 shares of PMV Pharmaceuticals worth $23.8K as of Q3 2026.
  • Jane Street sold 25,962 PMV Pharmaceuticals shares in Q3 2026, an estimated $33.6K.
  • PMV Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #11234 holding.
  • Jane Street first reported a position in PMV Pharmaceuticals in Q3 2020 and has held it in 16 quarters since.
  • Jane Street's PMV Pharmaceuticals position peaked at $1.12M in Q1 2023.
  • 36 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.